Saı̈k Urien

8.0k total citations
283 papers, 6.2k citations indexed

About

Saı̈k Urien is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Saı̈k Urien has authored 283 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Infectious Diseases, 63 papers in Molecular Biology and 59 papers in Oncology. Recurrent topics in Saı̈k Urien's work include HIV/AIDS drug development and treatment (58 papers), Pharmacological Effects and Toxicity Studies (39 papers) and Antibiotics Pharmacokinetics and Efficacy (37 papers). Saı̈k Urien is often cited by papers focused on HIV/AIDS drug development and treatment (58 papers), Pharmacological Effects and Toxicity Studies (39 papers) and Antibiotics Pharmacokinetics and Efficacy (37 papers). Saı̈k Urien collaborates with scholars based in France, United States and Switzerland. Saı̈k Urien's co-authors include Jean‐Marc Tréluyer, Jean‐Paul Tillement, E Albengres, Déborah Hirt, J P Tillement, François Lokiec, Philippe Lechat, Naïm Bouazza, Frantz Foissac and Sihem Benaboud and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Saı̈k Urien

278 papers receiving 6.0k citations

Peers

Countries citing papers authored by Saı̈k Urien

Since Specialization

Citations

This map shows the geographic impact of Saı̈k Urien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saı̈k Urien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saı̈k Urien more than expected).

Fields of papers citing papers by Saı̈k Urien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saı̈k Urien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saı̈k Urien. The network helps show where Saı̈k Urien may publish in the future.

Co-authorship network of co-authors of Saı̈k Urien

This figure shows the co-authorship network connecting the top 25 collaborators of Saı̈k Urien. A scholar is included among the top collaborators of Saı̈k Urien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saı̈k Urien. Saı̈k Urien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of human transplacental transfer of escitalopram, sertraline and paroxetine: an ex vivo cotyledon perfusion study 2025 ·Placenta ·(unknown), Naïm Bouazza, Frantz Foissac, (unknown), Saı̈k Urien, (unknown), (unknown), (unknown), Sihem Benaboud, Jean‐Marc Tréluyer, Gabrielle Lui	0
2	Optimization of vigabatrin dosage in children with epileptic spasms: A population pharmacokinetic approach 2024 ·British Journal of Clinical Pharmacology ·(unknown), Frantz Foissac, Naïm Bouazza, Inès Gana, Sihem Benaboud, (unknown), Déborah Hirt, Saı̈k Urien, Isabelle Desguerre, Jean‐Marc Tréluyer, Nicole Chémaly, Rima Nabbout	1
3	Impact of pediatric continuous renal replacement therapy parameters on meropenem, piperacillin, and tazobactam pharmacokinetics: an in vitro model 2024 ·Expert Opinion on Drug Metabolism & Toxicology ·Michaël Thy, (unknown), Saı̈k Urien, Naïm Bouazza, Frantz Foissac, (unknown), (unknown), Sihem Benaboud, Fabrice Lesage, Jean‐Marc Tréluyer, Gabrielle Lui, Mehdi Oualha	0
4	General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children 2022 ·British Journal of Clinical Pharmacology ·Naïm Bouazza, Aristides Dokoumetzidis, Catherijne A. J. Knibbe, Saskia N. de Wildt, Claire Ambery, Pieter De Cock, Elke Gasthuys, Frantz Foissac, Saı̈k Urien, Anna‐Karin Hamberg, Italo Poggesi, Wei Zhao, An Vermeulen, Joseph F. Standing, Jean‐Marc Tréluyer, (unknown)	2
5	Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy 2022 ·Antimicrobial Agents and Chemotherapy ·Michaël Thy, Saı̈k Urien, Frantz Foissac, Naïm Bouazza, Inès Gana, Emmanuelle Bille, (unknown), Julie Toubiana, Romain Berthaud, Fabrice Lesage, Sylvain Renolleau, Jean‐Marc Tréluyer, Sihem Benaboud, Mehdi Oualha	5
6	Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy 2022 ·Clinical Pharmacokinetics ·Michaël Thy, Saı̈k Urien, Naïm Bouazza, Frantz Foissac, Inès Gana, Emmanuelle Bille, (unknown), Julie Toubiana, Romain Berthaud, Fabrice Lesage, Sylvain Renolleau, Jean‐Marc Tréluyer, Sihem Benaboud, Mehdi Oualha	6
7	Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis 2018 ·Seminars in Arthritis and Rheumatism ·Brigitte Bader‐Meunier, Roman Krzysiek, I. Lemelle, (unknown), Aurélia Carbasse, Sylvaine Poignant, Isabelle Melki, Pierre Quartier, Laure Choupeaux, (unknown), Jean‐Marc Tréluyer, Alexandre Bélot, Salima Hacein‐Bey‐Abina, Saı̈k Urien	8
8	Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma 2016 ·Cancer Research ·Clémence Granier, Charles Dariane, Pierre Combe, Virginie Verkarre, Saı̈k Urien, Cécile Badoual, Hélène Roussel, Marion Mandavit, Patrice Ravel, Mathilde Sibony, Lucie Biard, C. Radulescu, Emeline Vinatier, Nadine Benhamouda, Michaël Peyromaure, Stéphane Oudard, Arnaud Méjean, Marc‐Olivier Timsit, Alain Gey, Éric Tartour	163
9	Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV 2015 ·PLoS ONE ·Patumrat Sripan, Sophie Le Cœur, Billy Amzal, (unknown), Patrinee Traisathit, Nicole Ngo‐Giang‐Huong, Kenneth McIntosh, Tim R. Cressey, (unknown), (unknown), (unknown), Jean‐Marc Tréluyer, Gonzague Jourdain, Marc Lallemant, Saı̈k Urien	1
10	Efavirenz Concentrations and Probability of HIV Replication in Children 2015 ·The Pediatric Infectious Disease Journal ·(unknown), Tim R. Cressey, Naïm Bouazza, (unknown), Linda Aurpibul, (unknown), (unknown), (unknown), Marc Lallemant, Lily Ingsrisawang, Nicolas Salvadori, Jean‐Marc Tréluyer, Saı̈k Urien, Gonzague Jourdain	6
11	Antiretroviral intensification to prevent intrapartum HIV transmission in late comers 2015 ·Journal of the International AIDS Society ·Marc Lallemant, Billy Amzal, Saı̈k Urien, Patumrat Sripan, Tim R. Cressey, Nicole Ngo‐Giang‐Huong, (unknown), (unknown), Thitiporn Siriwachirachai, (unknown), (unknown), (unknown), Suporn Koetsawang, Gonzague Jourdain, Sophie Le Cœur	3
12	Concentration-response Model of Lopinavir/Ritonavir in HIV-1–infected Pediatric Patients 2014 ·The Pediatric Infectious Disease Journal ·Naïm Bouazza, Saı̈k Urien, Stéphane Blanche, Déborah Hirt, Frantz Foissac, Sihem Benaboud, Jean‐Marc Tréluyer, Pierre Frange	9
13	Influence of Body Weight on Achieving Indinavir Concentrations Within Its Therapeutic Window in HIV-Infected Thai Patients Receiving Indinavir Boosted With Ritonavir 2011 ·Therapeutic Drug Monitoring ·Tim R. Cressey, Saı̈k Urien, Déborah Hirt, (unknown), (unknown), Chureeratana Bowonwatanuwong, Prattana Leenasirimakul, Jean‐Marc Tréluyer, Gonzague Jourdain, Marc Lallemant	4
14	Lopinavir/ritonavir population pharmacokinetics in neonates and infants 2011 ·British Journal of Clinical Pharmacology ·Saı̈k Urien, Ghislaine Firtion, Suzanne T. Anderson, Déborah Hirt, Caroline Solas, Gilles Peytavin, Albert Faye, Isabelle Thuret, Marthe Le Prevost, Carole Giraud, Hermione Lyall, Saye Khoo, Stéphane Blanche, Jean‐Marc Tréluyer	25
15	Pregnancy-Related Effects on Lamivudine Pharmacokinetics in a Population Study with 228 Women 2011 ·Antimicrobial Agents and Chemotherapy ·Sihem Benaboud, Jean‐Marc Tréluyer, Saı̈k Urien, Stéphane Blanche, Naïm Bouazza, Hélène Chappuy, Elisabeth Rey, E. Pannier, Ghislaine Firtion, Odile Launay, Déborah Hirt	34
16	Pharmacokinetic-Pharmacodynamic Modeling of Manganese After a Single Intravenous Infusion of Mangafodipir in Patients With Acute Alcoholic Hepatitis 2009 ·Therapeutic Drug Monitoring ·Déborah Hirt, Jean‐Philippe Richardet, Saı̈k Urien, Joël Poupon, Philippe Sogni, Frédéric Batteux, Alexis Laurent, (unknown), Marcel Debray, Jean‐Marc Tréluyer, Bernard Weill	3
17	An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study 2008 ·British Journal of Clinical Pharmacology ·Déborah Hirt, Bart Van Overmeire, Jean‐Marc Tréluyer, Jean‐Paul Langhendries, (unknown), (unknown), Paul Schepens, Saı̈k Urien	105
18	Tobacco Smoking Induces Expression of Very-High-Affinity Nicotine Binding Sites on Blood Polymorphonuclear Cells 1996 ·American Journal of Respiratory and Critical Care Medicine ·F. Lebargy, (unknown), Didier Morin, Roland Zini, Saı̈k Urien, Françoise Brée, J. Bignon, A Branellec, G Lagrue	35
19	Binding of 5-Methoxypsoralen to Blood Fractions 1993 ·Skin Pharmacology and Physiology ·Patrice Muret, (unknown), Saı̈k Urien, Pierre Agache, P Bechtel, Jean‐Paul Tillement	8
20	In vitro Studies on the Blood Distribution of Almitrine 1989 ·Pharmacology ·(unknown), (unknown), Saı̈k Urien, P Riant, Jean‐Paul Tillement	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact